Keywords: |
adult; clinical article; aged; diarrhea; conference paper; cytarabine; follow-up studies; lung toxicity; nephrotoxicity; bone marrow; antineoplastic combined chemotherapy protocols; drug administration schedule; fever; recombinant proteins; daunorubicin; acute myeloblastic leukemia; remission induction; neutrophils; leukocyte count; infusions, intravenous; recombinant granulocyte macrophage colony stimulating factor; intravenous drug administration; middle age; granulocyte-macrophage colony-stimulating factor; leukemia, myelocytic, acute; human; male; female
|